| ABCA1 antibodies | |
| This is a review about ABCA1 antibodies, based on 4 published articles using ABCA1 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited ABCA1 antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology ABCA1 products
includes other brands or spellings
|
| ip, wb | | Santa Cruz Biotechnology rabbit anti-human ABCA1 serum was used in Western blot and immunoprecipitation to study the biological function of apolipoprotein A-I. |
NOVUS BIOLOGICALS search Novus Biologicals ABCA1 products
includes other brands or spellings
|
| ip, wb | | Novus Biologicals ABCA1 antibody was used in western blot and immunoprecipitation to study ABCA1 phosphorylation and degradation. |
| wb | | Novus Biologicals polyclonal rabbit anti-human ABCA1 antibody was used in normal human fibroblasts and in western blot to study the normalization of lipid efflux to apoA-I and HDL particle formation in human NPC disease fibroblasts. |
| wb | | Novus Biologicals polyclonal rabbit anti-human ABCA1 antibody was used in western blot to study the effect of glycosphingolipid accumulation on cholesterol efflux. |
Articles Reviewed |
| 1. Yoshio Yamauchi et al. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. 2003 |
| 2. Elias N Glaros et al. Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator. 2005 |
| 3. Yutong Wang et al. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. 2005 |
| 4. Emmanuel Boadu et al. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. 2006 |
|